Published in BMJ on July 23, 2014
Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study. BMJ (2015) 2.54
Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays. Thromb J (2014) 1.05
Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review. PLoS Med (2016) 0.88
Enhanced elimination of dabigatran through extracorporeal methods. J Med Toxicol (2015) 0.76
Evaluation of the chromogenic anti-factor IIa assay to assess dabigatran exposure in geriatric patients with atrial fibrillation in an outpatient setting. Thromb J (2016) 0.76
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways. Front Pharmacol (2016) 0.76
Newer oral anticoagulants. Br Dent J (2015) 0.75
The hazards of rapid approval of new drugs. Aust Prescr (2016) 0.75
A left atrial appendage thrombus that developed during prophylactic low-dose dabigatran treatment resolved after switching to apixaban. Clin Case Rep (2017) 0.75
Emergency reversal of dabigatran for emergency surgery. BMJ Case Rep (2015) 0.75
Clinical utility of dabigatran in United Arab Emirates. A pharmacovigilance study. Saudi Med J (2015) 0.75
New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs). Nutrients (2015) 0.75
The Dabigatran debate. Glob Cardiol Sci Pract (2014) 0.75
Fostering Competence in Medicines Development: The IFAPP Perspective. Front Pharmacol (2016) 0.75
Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs? Br J Clin Pharmacol (2017) 0.75
Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies. BMJ (2017) 0.75
Alcohol and environmental justice: the density of liquor stores and bars in urban neighborhoods in the United States. J Stud Alcohol Drugs (2007) 2.66
Evaluation of the mental health benefits of yoga in a secondary school: a preliminary randomized controlled trial. J Behav Health Serv Res (2012) 2.39
Rivaroxaban: can we trust the evidence? BMJ (2016) 2.14
Understanding healing relationships in primary care. Ann Fam Med (2008) 2.08
Why have UK doctors been deterred from prescribing Avastin? BMJ (2015) 1.96
Economic analysis of physical activity interventions. Am J Prev Med (2011) 1.66
Speaking of weight: how patients and primary care clinicians initiate weight loss counseling. Prev Med (2004) 1.64
Medical device recalls and transparency in the UK. BMJ (2011) 1.58
European drugs agency clashes with scientists over safety of GLP-1 drugs. BMJ (2013) 1.50
Rejecting political correctness. BMJ (2005) 1.47
The neighborhood alcohol environment and alcohol-related morbidity. Alcohol Alcohol (2009) 1.41
How valid is the European Food Safety Authority's assessment of sports drinks? BMJ (2012) 1.40
Out and about: association of the built environment with physical activity behaviors of adolescent females. Health Place (2011) 1.37
Identifying walking trips from GPS and accelerometer data in adolescent females. J Phys Act Health (2011) 1.18
Etiological correlates of vaginismus: sexual and physical abuse, sexual knowledge, sexual self-schema, and relationship adjustment. J Sex Marital Ther (2003) 1.17
Quantifying the contribution of neighborhood parks to physical activity. Prev Med (2013) 1.15
What makes an orphan drug? BMJ (2010) 1.13
Multilevel spatio-temporal dual changepoint models for relating alcohol outlet destruction and changes in neighbourhood rates of assaultive violence. Geospat Health (2008) 1.12
Vaginal spasm, pain, and behavior: an empirical investigation of the diagnosis of vaginismus. Arch Sex Behav (2004) 1.12
The transcriptional repressor Mecp2 regulates terminal neuronal differentiation. Mol Cell Neurosci (2004) 1.07
Social capital and the neighborhood alcohol environment. Health Place (2008) 1.06
Determinants of social capital indicators at the neighborhood level: a longitudinal analysis of loss of off-sale alcohol outlets and voting. J Stud Alcohol Drugs (2007) 1.03
The accuracy of endoscopic ultrasound for restaging esophageal carcinoma after chemoradiation therapy. Cancer (2004) 1.03
Features of the Chronic Care Model (CCM) associated with behavioral counseling and diabetes care in community primary care. J Am Board Fam Med (2010) 0.98
Use of qualitative methods and user-centered design to develop customized health information technology tools within federally qualified health centers to keep children insured. J Ambul Care Manage (2014) 0.96
Revision rates for metal on metal hip joints are double that of other materials. BMJ (2011) 0.95
Neighbourhood alcohol availability and gonorrhea rates: impact of social capital. Geospat Health (2009) 0.92
Insiders criticise FDA's decision not to withdraw rosiglitazone. BMJ (2010) 0.92
PSA testing: press coverage in UK and US is an ocean apart. BMJ (2009) 0.91
HIV/AIDS is spreading fastest in eastern Europe and Asia. BMJ (2004) 0.90
The evidence underpinning sports performance products: a systematic assessment. BMJ Open (2012) 0.88
Will industry influence derail UN summit? BMJ (2011) 0.88
Impact of a new bicycle path on physical activity. Prev Med (2007) 0.88
Pressure mounts for companies to hand over data on antidiabetes drugs linked to pancreatic harm. BMJ (2013) 0.87
Performance enhancement using a balanced scorecard in a Patient-centered Medical Home. Fam Med (2011) 0.86
Concerns over data in key dabigatran trial. BMJ (2014) 0.85
Examining role change in primary care practice. J Prim Care Community Health (2012) 0.84
Proximity to urban parks and mental health. J Ment Health Policy Econ (2014) 0.83
EMA consults public on plan to increase transparency of drug trial data. BMJ (2013) 0.82
Barrier in West Bank threatens residents' health care, says report. BMJ (2005) 0.81
FDA is to assess data linking type 2 diabetes drugs with pancreatitis. BMJ (2013) 0.81
Reports of pancreatitis are 20-30 times more likely with GLP-1 drugs, analysis finds. BMJ (2013) 0.80
Devices and desires: industry fights toughening of medical device regulation in Europe. BMJ (2013) 0.80
Hispanic concentration and the conditional influence of collective efficacy on adolescent childbearing. Arch Pediatr Adolesc Med (2006) 0.79
The Affordable Care Act's plan for consumer assistance with insurance moves states forward but remains a work in progress. Health Aff (Millwood) (2013) 0.79
Investigations editor's reply to Holt and to Barnett and O'Hare. BMJ (2013) 0.78
Hyperplasia from GLP-1 drugs is "not a surprise," say researchers. BMJ (2013) 0.78
Rebuilding from the rubble. BMJ (2006) 0.77
Questions remain over safety and effectiveness of oseltamivir. BMJ (2012) 0.77
Asylum seekers in detention centres receive poor medical care, MP says. BMJ (2008) 0.77
Two drugs for type 2 diabetes seem to raise risk of acute pancreatitis, study shows. BMJ (2013) 0.77
Roche offers researchers access to all Tamiflu trials. BMJ (2013) 0.77
NICE rules out NHS prescription of fingolimod for multiple sclerosis. BMJ (2011) 0.76
Patients are let down by poor device regulation, warn surgeons. BMJ (2012) 0.76
Questioning the timeline of H1N1 flu vaccination contracts. Nature (2010) 0.75
Blair pledges 150m pounds sterling to support and protect AIDS orphans. BMJ (2004) 0.75
Agency tells surgeons not to use a type of hip implant cup liner because of high revision rates. BMJ (2012) 0.75
Who was who? Race and Jews in turn-of-the-century Britain. J Br Stud (2002) 0.75
BMA meeting: Doctors urge government to lower age limit for cervical cancer screening. BMJ (2009) 0.75
Overhaul US licensing process for devices, urges Institute of Medicine. BMJ (2011) 0.75
FDA puts rosiglitazone post-marketing trial on hold. BMJ (2010) 0.75
UK health secretary promises to tighten regulatory procedures for medical devices. BMJ (2012) 0.75
Environmental groups criticise WHO plans to improve health. BMJ (2004) 0.75
DePuy knew about hip implant's high failure rate three years before it was recalled. BMJ (2013) 0.75
Whistle while you work: an analysis of NHS foundation trust policies. BMJ (2010) 0.75
Study on metal-on-metal hip implants was halted a year before UK regulator banned their use. BMJ (2012) 0.75
Medical students should be added to GMC register, says judge. BMJ (2005) 0.75
Device licensing bodies sometimes put business before safety, an investigation finds. BMJ (2012) 0.75
MEP calls for tougher legislation to stop drug trials that could be considered as marketing. BMJ (2012) 0.75
European Medicines Agency tightens rules on conflict of interest. BMJ (2010) 0.75
Cancer drugs: high price, uncertain value. BMJ (2017) 0.75
US regulator seeks advice on health risks of metal on metal hip implants. BMJ (2012) 0.75
European regulatory body recommends suspension of rosiglitazone. BMJ (2010) 0.75
Medtronic submits full data on spinal protein to independent scrutiny. BMJ (2011) 0.75
Manufacturer failed to disclose faulty device in rivaroxaban trial. BMJ (2016) 0.75
New obesity center at WVU offering comprehensive program.. W V Med J (2003) 0.75
Are the odds shifting against pharma in the fight for cheaper treatment for macular degeneration? BMJ (2017) 0.75
WINDOW: wideband demodulator for optical waveforms. Opt Express (2017) 0.75
Home care nurses: a study of the occurrence of culturally competent care. J Transcult Nurs (2003) 0.75
Providing nomadic people with health care. BMJ (2005) 0.75
Source of surgical instruments should be checked, BMA says. BMJ (2008) 0.75
Commitment to tackling alcohol misuse is missing from UN summit declaration, experts say. BMJ (2011) 0.75
Donor countries should ensure donated funds reach health workers. BMJ (2007) 0.75
Attacks on publicly funded trials: what happens when industry does not want to know the answer. BMJ (2015) 0.75
Drugs agency grants its first licence to homoeopathic product. BMJ (2009) 0.75
Support for tomorrow's doctors: getting it right, meeting their needs. Occup Med (Lond) (2013) 0.75
Closing the vaccine gap among toddlers in N.J. family physicians' practices. J Okla State Med Assoc (2005) 0.75
European Medicines Agency is to tighten up on advisers' conflicts of interest. BMJ (2012) 0.75
My six day experience in the Middle East. BMJ (2005) 0.75